Home › Therapeutic areas › Oncology › Myelodysplastic Syndrome
Myelodysplastic Syndrome (3 companies)
Companies with an active program in Myelodysplastic Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics | HematologyImmunology+2 Rare | 1 | NDA Submitted | 10 |
| GERN | Geron | Oncology | 1 | Approved | 3 |
| MRKR | Marker Therapeutics | Oncology | 1 | Phase 1 | 4 |
No companies match.